InVESTOR RELATIONS

Corporate
Governance

BenevolentAI is committed to sound corporate governance practices.

BOARD & LEADERSHIP

Joanna Shields
CEO
Anne Phelan
CSO
Ivan Griffin
COO & Co-Founder
Nick Keher
CFO
Daniel Neil
CTO
Mark Davies
SVP Informatics and Data
Dave Michalovich
SVP Precision Medicine
Nikki Robas
VP Drug Discovery
Bryn Williams-Jones
SVP Drug Discovery
Ed Savory
VP Drug Discovery

Principles for the Ethical Deployment of AI

Lorem ipsum dolor sit amet, consectetur adipiscing elit. In id eget lectus ridiculus bibendum vitae, ut sed. Lobortis gravida adipiscing fringilla in dui fringilla et eu. Faucibus arcu auctor sed dictum tellus ac scelerisque viverra viverra. Laoreet etiam duis urna lobortis nunc. In velit et in tristique pharetra.

Corporate Policies

Audit Committee Terms

Nomination Committee Terms

Remuneration Committee Terms

Remuneration Policy

Whistleblower Policy

Related Person Transactions Policy

Equality, Diversity & Inclusion Policy

Antislavery/Human Rights Policy

Social Media Policy

Insider Trading Policy

Disclosure Policy

Code of Business Conduct and Ethics

Data Protection Policy

Anti-Bribery and Anti-Corruption Policy

Sanctions, Anti-Money Laundering, Policy and Counter-Terrorist Financing Policy

Rules of the Board of Directors

Investor Resources

Press Releases & Presentations

Email Alerts

Business Overview